Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluating the Safety and Efficacy of Ondansetron in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis
Sponsor: Tanta University
Summary
Endoscopic retrograde cholangiopancreatography (ERCP (, a key tool that is used in diagnosis and treatment of pancreato-biliary diseases. Post-ERCP pancreatitis (PEP) is the most common and serious complication that can occur following this procedure and can lead to significant morbidity and mortality. A variety of patient-related and procedure-related factors have been associated with higher rates of PEP.
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
44
Start Date
2025-03-01
Completion Date
2026-12-20
Last Updated
2026-03-13
Healthy Volunteers
No
Conditions
Interventions
Placebo
Placebo tablets will have the same look and appearance of ondansetron.
Ondansetron
ondansetron is commonly used as anti-emetics to prevent and treat chemotherapy-induced vomiting and nausea
Locations (1)
Tanta Unuversity
Tanta, Egypt